Author,Reference,Extractor_1,duplicate,preDM_def,combined_def,n_def,subgroup,mort_report,cardiomort_report,CVD_report,CHD_report,stroke_report,iscstroke_report,hemstroke_report,HF_report,CKD_report,cohort_name,country,year_pub,years_study,mean_followup,followup_reported value,multivar_adjust,var_adjust,populationlevel_comorobidity,n_participants,n_females,n_males,mean_age_1,mean_age_F,mean_age_M,FSG_unit,mean_FSG,mean_FSG_F,mean_FSG_M,percent_HBA1C,percent_HBA1C_F,percent_HBA1C_M,percent_CVD,percent_CVD_F,percent_CVD_M,percent_CAD,percent_CAD_F,percent_CAD_M,percent_HTN,percent_HTN_F,percent_HTN_M,percent_stroke,percent_stroke_F,percent_stroke_M,percent_smoker,percent_smoker_F,percent_smoker_M,mean_GFR,mean_GFR_F,mean_GFR_M,mean_BMI,mean_BMI_F,mean_BMI_M,mean_SBP,mean_SBP_F,mean_SBP_M,mean_DBP,mean_DBP_F,mean_DBP_M,outcome_type,n_mort,n_mort_F,n_mort_M,HR_mort_F,LCI_mort_F,UCI_mort_F,HR_mort_M,LCI_mort_M,UCI_mort_M,n_cardiomort,n_cardiomort_F,n_cardiomort_M,HR_cardiomort_F,LCI_cardiomort_F,UCI_cardiomort_F,HR_cardiomort_M,LCI_cardiomort_M,UCI_cardiomort_M,n_stroke,n_stroke_F,n_stroke_M,HR_stroke_F,LCI_stroke_F,UCI_stroke_F,HR_stroke_M,LCI_stroke_M,UCI_stroke_M,n_iscstroke,n_iscstroke_F,n_iscstroke_M,HR_iscstroke_F,LCI_iscstroke_F,UCI_iscstroke_F,HR_iscstroke_M,LCI_iscstroke_M,UCI_iscstroke_M,n_hemstroke,n_hemstroke_F,n_hemstroke_M,HR_hemstroke_F,LCI_hemstroke_F,UCI_hemstroke_F,HR_hemstroke_M,LCI_hemstroke_M,UCI_hemstroke_M,CVD_def,n_CVD,n_CVD_F,n_CVD_M,HR_CVD_F,LCI_CVD_F,UCI_CVD_F,HR_CVD_M,LCI_CVD_M,UCI_CVD_M,CHD_def,n_CHD,n_CHD_F,n_CHD_M,HR_CHD_F,LCI_CHD_F,UCI_CHD_F,HR_CHD_M,LCI_CHD_M,UCI_CHD_M,CKD_def,n_CKD,n_CKD_F,n_CKD_M,HR_CKD_F,LCI_CKD_F,UCI_CKD_F,HR_CKD_M,LCI_CKD_M,UCI_CKD_M,n_HF,n_HF_F,n_HF_M,HR_HF_F,LCI_HF_F,UCI_HF_F,HR_HF_M,LCI_HF_M,UCI_HF_M
"European Diabetes Epidemiology Group, 2001",3. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161(3):397-405.,James,1,1,NA,1,6.1-6.9 mmol/L,1,1,0,1,1,0,0,0,0,DECODE,Europe (various),2001,NA,NA,NA,1,"age, center, BMI, systolic blood pressure, serum cholesterol level, smoking status",NA,21062,6686,14376,53,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.2,NA,NA,140,NA,NA,82,NA,NA,0,485.58,27.9,457.68,1.2,0.81,1.79,1.1,0.99,1.22,138.929,11.16,127.769,1.53,0.81,2.9,1.03,0.85,1.25,29.627,4.836,24.791,3.02,1.11,8.21,0.89,0.57,1.37,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Causes of death were classified using the International Classification of Diseases, Eighth and Ninth Revision, codes 401-448 (CVD), 410-414 (coronary heart disease [CHD]), and 430-438 (stroke).",69.721,2.976,66.745,1.25,0.39,4.03,1.05,0.8,1.37,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"European Diabetes Epidemiology Group, 2001",3. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161(3):397-405.,James,1,2,NA,1,7.8-11.0 mmol/L,1,1,0,1,1,0,0,0,0,DECODE,Europe (various),2001,NA,NA,NA,1,"age, center, BMI, systolic blood pressure, serum cholesterol level, smoking status",NA,21062,6686,14376,53,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.2,NA,NA,140,NA,NA,82,NA,NA,0,558.944,95.172,463.772,1.25,0.98,1.58,1.42,1.28,1.57,192.31,38.808,153.502,1.28,0.88,1.86,1.34,1.12,1.6,38.634,9.24,29.394,1.21,0.56,2.59,1.25,0.84,1.88,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Causes of death were classified using the International Classification of Diseases, Eighth and Ninth Revision, codes 401-448 (CVD), 410-414 (coronary heart disease [CHD]), and 430-438 (stroke).",104.814,16.632,88.182,1.22,0.69,2.15,1.29,1.02,1.64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Doi et al., 2010","47. Doi Y, Ninomiya T, Hata J, Fukuhara M, Yonemoto K, Iwase M, et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2010;41(2):203-9.",James,2,0,NA,1,5.6-6.0 mmol/L,0,0,0,1,0,1,0,0,0,Hisayama Study,Japan,2009,1988-2002,14,NA,1,"age, systolic blood pressure, electrocardiogram abnormalities, body mass index, total and high-density lipoprotein cholesterol, smoking habits, alcohol intake, and regular exercise.",NA,2130.165,1249.752,880.413,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31,18,13,0.98,0.54,1.79,0.66,0.33,1.29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHD included acute myocardial infarction, silent myocardial infarction, sudden cardiac death within 1 hour after the onset of acute illness, and coronary artery disease treated by coronary artery bypass surgery or angioplasty.",25,9,16,1.13,0.47,2.71,0.67,0.37,1.23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Doi et al., 2010","47. Doi Y, Ninomiya T, Hata J, Fukuhara M, Yonemoto K, Iwase M, et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2010;41(2):203-9.",James,2,0,NA,1,6.1-6.9 mmol/L,0,0,0,1,0,1,0,0,0,Hisayama Study,Japan,2009,1988-2002,14,NA,1,"age, systolic blood pressure, electrocardiogram abnormalities, body mass index, total and high-density lipoprotein cholesterol, smoking habits, alcohol intake, and regular exercise.",NA,2130.165,1249.752,880.413,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23,14,9,1.59,0.8,3.13,0.68,0.3,1.54,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHD included acute myocardial infarction, silent myocardial infarction, sudden cardiac death within 1 hour after the onset of acute illness, and coronary artery disease treated by coronary artery bypass surgery or angioplasty.",20,6,14,1.36,0.49,3.81,0.8,0.42,1.54,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Doi et al., 2010","47. Doi Y, Ninomiya T, Hata J, Fukuhara M, Yonemoto K, Iwase M, et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2010;41(2):203-9.",James,2,2,NA,1,7.8-11.0 mmol/L,0,0,0,1,0,1,0,0,0,Hisayama Study,Japan,2009,1988-2002,14,NA,1,"age, systolic blood pressure, electrocardiogram abnormalities, body mass index, total and high-density lipoprotein cholesterol, smoking habits, alcohol intake, and regular exercise.",NA,2130.165,1249.752,880.413,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,28,15,13,0.99,0.51,1.92,1.05,0.52,2.13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHD included acute myocardial infarction, silent myocardial infarction, sudden cardiac death within 1 hour after the onset of acute illness, and coronary artery disease treated by coronary artery bypass surgery or angioplasty.",24,6,18,0.82,0.29,2.29,0.97,0.53,1.77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Kokubo et al., 2010","49. Kokubo Y, Okamura T, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, et al. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study. Hypertens Res 2010;33(12):1238-43.",James,3,0,NA,0,IFG,0,0,1,1,1,0,0,0,0,Suita Study,Japan,2010,1989-1994,11.7,0,1,"age, BMI, hypertension, hyperlipidemia, smoking and drinking status",NA,5069,2737,2332,54.28112054,53.56265985,55.12435678,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,28.76879069,25.91121666,32.12264151,NA,NA,NA,31.2708621,12.33028864,53.50085763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,69,28,41,1.36,0.84,2.19,0.97,0.64,1.46,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CVD was defined as stroke or CHD.,139,48,91,1.49,1.02,2.16,1.13,0.85,1.51,"first ever acute myocardial infarction, sudden cardiac death within 24 h after the onset of acute illness or coronary artery disease followed by coronary artery bypass surgery or angioplasty",70,20,50,1.83,1.01,3.32,1.31,0.87,1.96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Magliano et al., 2010","50. Magliano DJ, Soderberg S, Zimmet PZ, Cartensen B, Balkau B, Pauvaday V, et al. Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose tolerance. Diabetes Care 2010;33(9):1983-9.",James,4,5,<7 FPG ?? and OGTT 2hPG,1,IGT,1,1,0,0,0,0,0,0,0,NA,Mauritius,2010,1987-2007,15.1,1,1,"Waist/hip circumference, smoking, hypertension, ethnicity, prior CVD, education, HDL cholesterol, triglycerides, total cholesterol",NA,8946,4844,4102,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,0.9,0.56,1.45,1.13,0.82,1.56,NA,NA,NA,0.66,0.32,1.38,1.24,0.82,1.87,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Magliano et al., 2010","50. Magliano DJ, Soderberg S, Zimmet PZ, Cartensen B, Balkau B, Pauvaday V, et al. Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose tolerance. Diabetes Care 2010;33(9):1983-9.",James,4,1,NA,1,IFG,1,1,0,0,0,0,0,0,0,NA,Mauritius,2010,1987-2007,15.1,1,1,"Waist/hip circumference, smoking, hypertension, ethnicity, prior CVD, education, HDL cholesterol, triglycerides, total cholesterol",NA,8946,4844,4102,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,1.21,0.96,1.53,1.39,1.12,1.71,NA,NA,NA,1.16,0.84,1.59,1.37,1.02,1.83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Madssen et al., 2012","58. Madssen E, Vatten L, Nilsen TI, Midthjell K, Wiseth R, Dale AC. Abnormal glucose regulation and gender-specific risk of fatal coronary artery disease in the HUNT 1 study. Scand Cardiovasc J 2012;46(4):219-25.",James,5,5,WHO FPG and OGTT 2hPG,1,IGR,0,0,0,1,0,0,0,0,0,HUNT 1,Norway,2012,1984-2003,18,NA,1,"Age, BMI, hypertension, established cardiovascular disease, smoking habits, exercise sessions per week",NA,45530,23381,22149,59.49654733,59.87167358,59.10055533,0,5.217687239,5.014220949,5.432470992,NA,NA,NA,9.661016912,7.568260553,11.87017924,NA,NA,NA,44.37781902,44.67963731,44.05921261,NA,NA,NA,25.28037997,20.02434455,30.82877331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Deaths from CAD were classified according to the International Classifi cation of Disease (ICD-9: 390– 459 and ICD-10: 100– 99,66,20,46,1.2,0.8,1.9,1.2,0.9,1.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Gordon-Dseagu et al., 2015","68. Gordon-Dseagu VL, Mindell JS, Steptoe A, Moody A, Wardle J, Demakakos P, et al. Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data. PLoS One 2015;10(3):e0119882.",James,6,3,NA,0,Prediabetes,1,1,0,0,0,0,0,0,0,Health Survey for England (HSE),UK,2015,2003-2008,7,0,1,"Age, sex, smoking status, SES, BMI",NA,20674,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,0.99,0.83,1.18,0.92,0.77,1.09,NA,NA,NA,1.06,0.76,1.46,1.08,0.81,1.45,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Hadaegh et al., 2015","69. Hadaegh F, Ehteshami-Afshar S, Hajebrahimi MA, Hajsheikholeslami F, Azizi F. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up. Int J Cardiol 2015;182:334-9.",James,7,5,ADA FPG and/or OGTT 2hPG,1,Prediabetes,1,0,1,1,0,0,0,0,0,TLGS,Iran,2015,1999-2012,12.1,1,1,"Age, hypertension, hypercholesterolemia, BMI, smoking",NA,1538,815,723,59.51252276,58.55920245,60.58715076,0,5.15130039,5.158834356,5.142807746,NA,NA,NA,19.42126138,13.9988935,25.1007362,16.18348505,12.39558282,20.45338866,NA,NA,NA,NA,NA,NA,11.13654096,2.969570552,20.34273859,NA,NA,NA,27.55692458,28.91404908,26.02710927,129.9758973,130.8711043,128.9667773,81.03693108,81.78817178,80.19009682,0,NA,NA,NA,1.35,0.78,2.3,0.99,0.64,1.55,NA,NA,NA,1.06,0.76,1.46,1.08,0.81,1.45,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CVD was specified as a composite measure of any CHD events, stroke, or cerebrovascular events",NA,NA,NA,1.67,1.16,2.41,0.863,0.63,1.29,"cases of definite MI diagnosed by ECG and biomarkers, probable MI (positive ECG findings plus cardiac symptoms or signs and
biomarkers showing negative or equivocal results), unstable angina pectoris (new cardiac symptoms or changing symptom patterns and positive ECG findings with normal biomarkers) and angiographic proven CHD. ",NA,NA,NA,1.8,1.21,2.68,0.83,0.58,1.18,NA,NA,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Warren et al., 2017","82. Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2017;5(1):34-42.",James,8,0,NA,1,5.6-6.9 mmol/L,1,0,1,0,0,0,0,0,1,ARIC,USA,2017,1987-2013,NA,NA,1,"age, sex (male, female), race-center (white, Minneapolis, MN; black, Jackson, MS; white, Washington County, MD; black, Forsyth County, NC; white, Forsyth County, NC), education level (less than high school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension (yes, no), eGFR, smoking status (current, former, never), drinking status (current, former, never), lipid-lowering medication use (yes, no), family history of diabetes (yes, no)school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension , eGFR, smoking status (current, former, never), drinking status (current, former,
never), lipid-lowering medication use  family history of diabetes ",NA,6862,4007,2855,62.76243078,NA,NA,0,5.374060041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,39.74584669,NA,NA,NA,NA,NA,14,NA,NA,88.23121539,NA,NA,28.24281551,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,1.27,1.08,1.51,1.01,0.87,1.17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"any coronary heart disease hospital admission or death, or ischaemic stroke hospital admission or death, and were obtained by continuous active surveillance. ",NA,NA,NA,1.17,0.91,1.5,1.06,0.86,1.31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min per 1·73 m² measured at a study visit and a reduction in eGFR of at least 25% from the baseline visit to the follow-up visit, or chronic kidney disease-related hospital admission or death by continuous active surveillance, or an end-stage renal disease event identified by the US Renal Data System registry",NA,NA,NA,0.97,0.82,1.15,0.87,0.74,1.03,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Warren et al., 2017","82. Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2017;5(1):34-42.",James,8,1,NA,1,6.1-6.9 mmol/L,1,0,1,0,0,0,0,0,1,ARIC,USA,2017,1987-2014,NA,NA,1,"age, sex (male, female), race-center (white, Minneapolis, MN; black, Jackson, MS; white, Washington County, MD; black, Forsyth County, NC; white, Forsyth County, NC), education level (less than high school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension (yes, no), eGFR, smoking status (current, former, never), drinking status (current, former, never), lipid-lowering medication use (yes, no), family history of diabetes (yes, no)school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension , eGFR, smoking status (current, former, never), drinking status (current, former,
never), lipid-lowering medication use  family history of diabetes ",NA,6862,4005.948,2856.052,62.73619936,NA,NA,0,5.367693092,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,39.76652579,NA,NA,NA,NA,NA,14.1095016,NA,NA,88.21809968,NA,NA,28.18959487,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,1.32,1.01,1.72,1.24,1.01,1.53,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"any coronary heart disease hospital admission or death, or ischaemic stroke hospital admission or death, and were obtained by continuous active surveillance. ",NA,NA,NA,1.11,0.75,1.64,0.91,0.67,1.24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min per 1·73 m² measured at a study visit and a reduction in eGFR of at least 25% from the baseline visit to the follow-up visit, or chronic kidney disease-related hospital admission or death by continuous active surveillance, or an end-stage renal disease event identified by the US Renal Data System registry",NA,NA,NA,1.29,1.01,1.6,0.89,0.69,1.13,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Warren et al., 2017","82. Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2017;5(1):34-42.",James,8,2,NA,1,7.8-11.0 mmol/L,1,0,1,0,0,0,0,0,1,ARIC,USA,2017,1987-2015,NA,NA,1,"age, sex (male, female), race-center (white, Minneapolis, MN; black, Jackson, MS; white, Washington County, MD; black, Forsyth County, NC; white, Forsyth County, NC), education level (less than high school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension (yes, no), eGFR, smoking status (current, former, never), drinking status (current, former, never), lipid-lowering medication use (yes, no), family history of diabetes (yes, no)school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension , eGFR, smoking status (current, former, never), drinking status (current, former,
never), lipid-lowering medication use  family history of diabetes ",NA,6451,3718,2733,62.56713688,NA,NA,0,5.347198884,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,38.35994419,NA,NA,NA,NA,NA,14.75430166,NA,NA,88.22456983,NA,NA,28.16713688,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,1.08,0.91,1.28,1.27,1.09,1.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"any coronary heart disease hospital admission or death, or ischaemic stroke hospital admission or death, and were obtained by continuous active surveillance. ",NA,NA,NA,0.91,0.71,1.18,1.03,0.81,1.29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min per 1·73 m² measured at a study visit and a reduction in eGFR of at least 25% from the baseline visit to the follow-up visit, or chronic kidney disease-related hospital admission or death by continuous active surveillance, or an end-stage renal disease event identified by the US Renal Data System registry",NA,NA,NA,1.11,0.94,1.32,1.04,0.86,1.25,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Warren et al., 2017","82. Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2017;5(1):34-42.",James,8,3,NA,1,5.7-6.4%,1,0,1,0,0,0,0,0,1,ARIC,USA,2017,1987-2016,NA,NA,1,"age, sex (male, female), race-center (white, Minneapolis, MN; black, Jackson, MS; white, Washington County, MD; black, Forsyth County, NC; white, Forsyth County, NC), education level (less than high school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension (yes, no), eGFR, smoking status (current, former, never), drinking status (current, former, never), lipid-lowering medication use (yes, no), family history of diabetes (yes, no)school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension , eGFR, smoking status (current, former, never), drinking status (current, former,
never), lipid-lowering medication use  family history of diabetes ",NA,10382,5892,4490,57.07333847,NA,NA,0,5.487620882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35.78587941,NA,NA,NA,NA,NA,21.56193412,NA,NA,97.07333847,NA,NA,27.44905606,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,1.45,1.28,1.65,1.22,1.08,1.37,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"any coronary heart disease hospital admission or death, or ischaemic stroke hospital admission or death, and were obtained by continuous active surveillance. ",NA,NA,NA,1.53,1.27,1.85,1.33,1.13,1.56,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min per 1·73 m² measured at a study visit and a reduction in eGFR of at least 25% from the baseline visit to the follow-up visit, or chronic kidney disease-related hospital admission or death by continuous active surveillance, or an end-stage renal disease event identified by the US Renal Data System registry",NA,NA,NA,1.26,1.09,1.45,1.29,1.12,1.48,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Warren et al., 2017","82. Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2017;5(1):34-42.",James,8,4,NA,1,6.0-6.4%,1,0,1,0,0,0,0,0,1,ARIC,USA,2017,1987-2017,NA,NA,1,"age, sex (male, female), race-center (white, Minneapolis, MN; black, Jackson, MS; white, Washington County, MD; black, Forsyth County, NC; white, Forsyth County, NC), education level (less than high school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension (yes, no), eGFR, smoking status (current, former, never), drinking status (current, former, never), lipid-lowering medication use (yes, no), family history of diabetes (yes, no)school, high school or equivalent, college or above), BMI, waist-to-hip ratio, total cholesterol, HDL, triglycerides, hypertension , eGFR, smoking status (current, former, never), drinking status (current, former,
never), lipid-lowering medication use  family history of diabetes ",NA,10382,5921.908,4460.092,57.3383811,NA,NA,0,5.510325329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,30.10652595,NA,NA,NA,NA,NA,21.49384198,NA,NA,97.55691325,NA,NA,27.60518978,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,1.41,1.2,1.66,1.3,1.12,1.51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"any coronary heart disease hospital admission or death, or ischaemic stroke hospital admission or death, and were obtained by continuous active surveillance. ",NA,NA,NA,1.53,1.22,1.93,1.54,1.27,1.88,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min per 1·73 m² measured at a study visit and a reduction in eGFR of at least 25% from the baseline visit to the follow-up visit, or chronic kidney disease-related hospital admission or death by continuous active surveillance, or an end-stage renal disease event identified by the US Renal Data System registry",NA,NA,NA,1.29,1.08,1.55,1.32,1.1,1.59,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Ahn et al., 2018","83. Ahn SV, Kim HC, Nam CM, Suh I. Sex difference in the effect of the fasting serum glucose level on the risk of coronary heart disease. J Cardiol 2018;71(2):149-154.",James,9,0,NA,0,100-109 mg/dL,0,0,0,1,0,0,0,0,0,KMIC,South Korea,2018,1990-2003,11,NA,1,"Age, BMI, blood pressure, total cholesterol level, cigarette smoking status",NA,155924,59077,96847,43.84701136,42.35622831,44.75639411,1,88.15237167,85.43012509,89.81295136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,34.62881789,0.003075663964,55.75063864,NA,NA,NA,22.96569162,22.26832608,23.39108697,121.6110984,116.0240483,125.0192179,79.43613555,75.46781996,81.85682158,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHD was defined by the International Classification of Diseases, 10th revision (ICD-10) codes I20-I25 [angina pectoris, acute myocardial infarction (MI), subsequent acute MI, other acute ischemic heart disease, and chronic ischemic heart disease]",366,49,317,1.17,0.9,1.52,1,0.9,1.12,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Ahn et al., 2018","83. Ahn SV, Kim HC, Nam CM, Suh I. Sex difference in the effect of the fasting serum glucose level on the risk of coronary heart disease. J Cardiol 2018;71(2):149-154.",James,9,0,NA,0,110-125 mg/dL,0,0,0,1,0,0,0,0,0,KMIC,South Korea,2018,1990-2003,11,NA,1,"Age, BMI, blood pressure, total cholesterol level, cigarette smoking status",NA,155924,59077,96847,43.84701136,42.35622831,44.75639411,1,88.15237167,85.43012509,89.81295136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,34.62881789,0.003075663964,55.75063864,NA,NA,NA,22.96569162,22.26832608,23.39108697,121.6110984,116.0240483,125.0192179,79.43613555,75.46781996,81.85682158,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHD was defined by the International Classification of Diseases, 10th revision (ICD-10) codes I20-I25 [angina pectoris, acute myocardial infarction (MI), subsequent acute MI, other acute ischemic heart disease, and chronic ischemic heart disease]",180,19,161,1.62,1.11,2.36,1.07,0.92,1.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Ares et al., 2019","86. Ares J, Valdes S, Botas P, Sanchez-Ragnarsson C, Rodriguez-Rodero S, Morales-Sanchez P, et al. Mortality risk in adults according to categories of impaired glucose metabolism after 18 years of follow-up in the North of Spain: The Asturias Study. PLoS One 2019;14(1):e0211070.",James,10,5,ADA FPG and/or OGTT 2hPG,1,Prediabetes,1,1,0,0,0,0,0,0,0,Asturias Study,Spain,2019,1998-1999,18,NA,1,"Age, sex, BMI, history of high BP, smoking habits, LDL-C, glomerular filtration rate, and the prior presence of cardiovascular disease",NA,903,505,398,51.72735327,NA,NA,1,94.51694352,NA,NA,5.09833887,NA,NA,3.433001107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.83986711,NA,NA,79.98593577,NA,NA,27.28671096,NA,NA,131.4974529,NA,NA,82.52569214,NA,NA,0,142,NA,NA,0.96,0.56,1.62,0.89,0.55,1.41,NA,NA,NA,1.04,0.44,2.5,1.35,0.58,3.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Parizadeh et al., 2019","90. Parizadeh D, Rahimian N, Akbarpour S, Azizi F, Hadaegh F. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study. Eur J Prev Cardiol 2019;26(10):1080-1091.",James,11,0,NA,1,5.6-6.9 mmol/L,1,0,0,1,1,0,0,0,1,TLGS,Iran,2019,1999-2005,12,NA,1,"age, body mass index, education level, waist/hip ratio, total cholesterol, high-density lipoprotein cholesterol, triglycerides, estimated glomerular filtration rate, smoking, lipid-lowering drug, prevalent cardiovascular disease; additional adjustments were ahypertension, family history of diabetes;",NA,3311,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,1.09,0.72,1.66,1,0.73,1.35,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.3,0.69,2.44,1.36,0.78,2.37,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"International Classification of Diseases, 10th Revision Rubric (CHD:Rubric I20–I25",NA,NA,NA,1.27,0.93,1.75,0.83,0.63,1.08,CKD was defined as eGFR <60 mL/min per 1.73 m2,NA,NA,NA,1.01,0.82,1.23,1.28,0.99,1.63,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Parizadeh et al., 2019","90. Parizadeh D, Rahimian N, Akbarpour S, Azizi F, Hadaegh F. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study. Eur J Prev Cardiol 2019;26(10):1080-1091.",James,11,1,NA,1,6.1-6.9 mmol/L,1,0,0,1,1,0,0,0,1,TLGS,Iran,2019,1999-2005,12,NA,1,"age, body mass index, education level, waist/hip ratio, total cholesterol, high-density lipoprotein cholesterol, triglycerides, estimated glomerular filtration rate, smoking, lipid-lowering drug, prevalent cardiovascular disease; additional adjustments were ahypertension, family history of diabetes;",NA,3311,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,0.86,0.45,1.67,0.78,0.48,1.26,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.84,0.29,2.39,2.15,1.08,4.27,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"International Classification of Diseases, 10th Revision Rubric (CHD:Rubric I20–I25",NA,NA,NA,1.24,0.79,1.95,0.93,0.62,1.41,CKD was defined as eGFR <60 mL/min per 1.73 m2,NA,NA,NA,0.86,0.63,1.18,1.01,0.66,1.52,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Parizadeh et al., 2019","90. Parizadeh D, Rahimian N, Akbarpour S, Azizi F, Hadaegh F. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study. Eur J Prev Cardiol 2019;26(10):1080-1091.",James,11,2,NA,1,7.8-11.0 mmol/L,1,0,0,1,1,0,0,0,1,TLGS,Iran,2019,1999-2005,12,NA,1,"age, body mass index, education level, waist/hip ratio, total cholesterol, high-density lipoprotein cholesterol, triglycerides, estimated glomerular filtration rate, smoking, lipid-lowering drug, prevalent cardiovascular disease; additional adjustments were ahypertension, family history of diabetes;",NA,3198,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,1.26,0.83,1.9,1.18,0.88,1.64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.61,0.28,1.27,1.31,0.72,2.38,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"International Classification of Diseases, 10th Revision Rubric (CHD:Rubric I20–I25",NA,NA,NA,1.57,1.14,2.16,0.98,0.73,1.31,CKD was defined as eGFR <60 mL/min per 1.73 m2,NA,NA,NA,0.83,0.67,1.02,1.11,0.83,1.5,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Rhee et al., 2020","95. Rhee EJ, Jung I, Kwon H, et al. Increased Mortality Burden in Young Asian Subjects with Dysglycemia and Comorbidities. J Clin Med. 2020;9: pii: E1042.",James,12,0,NA,0,IFG,1,0,0,0,0,0,0,0,0,NHIS (KNHS),South Korea,2020,2009-2016,7.3,1,1,"age, sex, current smoking, alcohol drinking, regular exercise, body mass index, hypertension, dyslipidemia and chronic kidney disease",NA,5617468,2472828,3144640,46.9,NA,NA,1,92.9,NA,NA,NA,NA,NA,2.8,NA,NA,NA,NA,NA,27.28,NA,NA,NA,NA,NA,26.4,NA,NA,NA,NA,NA,23.7,NA,NA,122.5,NA,NA,76.5,NA,NA,0,52650,17024,35626,1.061,1.042,1.081,1.044,1.031,1.058,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Kim et al., 2013","60. Kim HK, Kim CH, Kim EH, Bae SJ, Choe J, Park JY, et al. Impaired fasting glucose and risk of cardiovascular disease in Korean men and women: the Korean Heart Study. Diabetes Care 2013;36(2):328-35.",James,13,0,NA,0,100-109 mg/dL,0,0,1,1,0,1,1,0,0,Korean Heart Study,South Korea,2013,1996-2004,10,0,1,"age, systolic blood pressure, antihypertensive medication, LDL cholesterol, HDL cholesterol, current smoking, BMI, and family history of CVD.",NA,357407,140651.667,216755.333,52.66017312,NA,NA,1,99.06747596,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.67462852,NA,NA,NA,NA,NA,36.91782949,NA,NA,NA,NA,NA,25.78443589,NA,NA,131.8885528,NA,NA,83.12494663,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,648,238,132,1,0.87,1.16,1.03,0.92,1.16,306,114,192,1.06,0.86,1.3,1.05,0.89,1.23,"The latter category included hypertensive disease (ICD-10 codes I10– I15), IHD (ICD-10 codes I20–I25), hemorrhagic stroke (ICD-10 codes I60–I62), ischemic stroke (ICD-10 code I63), other stroke (ICD-10 codes I64–I69), other disease likely related to atherosclerotic CVD (ICD-10 codes I44–I51), sudden death (ICD-10 code R96), and other vascular disease (ICD-10 codes I70–I74).",5107,1898,3209,1.04,0.99,1.09,1.01,0.97,1.05,IHD alone (ICD-10 codes I20–I25);,1712,526,1186,1.09,0.99,1.2,1.06,0.99,1.13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Kim et al., 2013","60. Kim HK, Kim CH, Kim EH, Bae SJ, Choe J, Park JY, et al. Impaired fasting glucose and risk of cardiovascular disease in Korean men and women: the Korean Heart Study. Diabetes Care 2013;36(2):328-35.",James,13,0,NA,0,110-125 mg/dL,0,0,1,1,0,1,1,0,0,Korean Heart Study,South Korea,2013,1996-2004,10,0,1,"age, systolic blood pressure, antihypertensive medication, LDL cholesterol, HDL cholesterol, current smoking, BMI, and family history of CVD.",NA,357407,140651.667,216755.333,52.66017312,NA,NA,1,99.06747596,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.67462852,NA,NA,NA,NA,NA,36.91782949,NA,NA,NA,NA,NA,25.78443589,NA,NA,131.8885528,NA,NA,83.12494663,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,347,109,238,1.07,0.88,1.31,1.24,1.08,1.43,135,36,99,0.82,0.59,1.16,1.17,0.94,1.45,"The latter category included hypertensive disease (ICD-10 codes I10– I15), IHD (ICD-10 codes I20–I25), hemorrhagic stroke (ICD-10 codes I60–I62), ischemic stroke (ICD-10 code I63), other stroke (ICD-10 codes I64–I69), other disease likely related to atherosclerotic CVD (ICD-10 codes I44–I51), sudden death (ICD-10 code R96), and other vascular disease (ICD-10 codes I70–I74).",2360,749,1611,0.96,0.89,1.04,1.1,1.05,1.17,IHD alone (ICD-10 codes I20–I25);,801,197,604,0.97,0.84,1.13,1.18,1.08,1.29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Donahue et al., 2011","10. Donahue RP, Dorn JM, Stranges S, Swanson M, Hovey K, Trevisan M. Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience. Nutr Metab Cardiovasc Dis 2011;21(7):504-11.",James,14,0,NA,0,IFG,0,0,1,0,0,0,0,0,0,Western New York Acute MI Study,USA,2011,1996-2004,4.5,0,1,"age, current smoker (yes vs. otherwise), Ever use alcohol (yes vs. otherwise), hypertension(yes vs. otherwise), hypercholesterolemia (yes vs. otherwise), aspirin use (yes vs. otherwise), BMI (continuous).",Survivors of first acute MI,986,259,757,54.6851927,56.396139,51.9326288,1,184.9329615,195.9027027,173.8508587,NA,NA,NA,NA,NA,NA,NA,NA,NA,43.85588235,51.88378378,39.37120211,NA,NA,NA,16.42849899,22.67799228,13.63923382,NA,NA,NA,29.41450304,29.16138996,27.36208719,114.5271805,114.8718147,109.8705416,70.79432049,69.54749035,68.48507266,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HD and stroke (ICD 410-414,427,430-439), PTCA or angioplasty",NA,NA,NA,2.24,1.2,4.18,0.83,0.57,1.21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Kim et al., 2016","Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans Hong-Kyu KIM,1 Jung Bok LEE,2 Seon Ha KIM,3 Min-Woo JO,3 Eun Hee KIM,1 Jenie Yoonoo HWANG,1 Sung Jin BAE,1 Chang Hee JUNG,4 Woo Je LEE,4 Joong-Yeol PARK,4 Gyung-Min PARK,5 Young-Hak KIM5 and Jaewon CHOE1",James,15,0,NA,1,100-125 mg/dL,0,0,1,1,0,0,0,0,0,Asan Medical Centre,South Korea,2015,2007-2011,3.1,1,1,"age, sex, hypertension, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, smoking, a family history of CVD, and body mass index.",NA,70035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Major CVD events were also defined as a composite of cardiovascular death, MI, stroke (hemorrhagic and ischemic), coronary revascularization, and hospitalization with IHD",222,NA,NA,1.39,0.95,2.04,0.95,0.75,1.22,"Cardiovascular death, MI, revascularization, and hospitalization with IHD were classified as major IHD events",120,NA,NA,1.97,0.97,3.99,0.92,0.71,1.21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Kim et al., 2016","Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans Hong-Kyu KIM,1 Jung Bok LEE,2 Seon Ha KIM,3 Min-Woo JO,3 Eun Hee KIM,1 Jenie Yoonoo HWANG,1 Sung Jin BAE,1 Chang Hee JUNG,4 Woo Je LEE,4 Joong-Yeol PARK,4 Gyung-Min PARK,5 Young-Hak KIM5 and Jaewon CHOE1",James,15,3,NA,1,5.7%-6.4%,0,0,1,1,0,0,0,0,0,Asan Medical Centre,South Korea,2015,2007-2012,3.1,1,1,"age, sex, hypertension, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, smoking, a family history of CVD, and body mass index.",NA,70082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Major CVD events were also defined as a composite of cardiovascular death, MI, stroke (hemorrhagic and ischemic), coronary revascularization, and hospitalization with IHD",191,NA,NA,1.18,0.79,1.77,1.22,0.94,1.59,"Cardiovascular death, MI, revascularization, and hospitalization with IHD were classified as major IHD events",112,NA,NA,2.27,1.1,4.7,1.54,1.17,2.03,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Kim et al., 2016","Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans Hong-Kyu KIM,1 Jung Bok LEE,2 Seon Ha KIM,3 Min-Woo JO,3 Eun Hee KIM,1 Jenie Yoonoo HWANG,1 Sung Jin BAE,1 Chang Hee JUNG,4 Woo Je LEE,4 Joong-Yeol PARK,4 Gyung-Min PARK,5 Young-Hak KIM5 and Jaewon CHOE1",James,15,5,ADA FPG and ADA HbA1c,1,100-125 mg/dL & 5.7%-6.4%,0,0,1,1,0,0,0,0,0,Asan Medical Centre,South Korea,2015,2007-2013,3.1,1,1,"age, sex, hypertension, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, smoking, a family history of CVD, and body mass index.",NA,69504,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Major CVD events were also defined as a composite of cardiovascular death, MI, stroke (hemorrhagic and ischemic), coronary revascularization, and hospitalization with IHD",303,NA,NA,1.48,1.02,2.16,1.99,0.78,1.26,"Cardiovascular death, MI, revascularization, and hospitalization with IHD were classified as major IHD events",168,NA,NA,3.01,1.36,6.68,1.17,0.89,1.52,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Huang et al., 2020","Huang YQ, Liu L, Huang JY, Chen CL, Yu YL, Lo K, Feng YQ. Prediabetes and risk for all-cause and cardiovascular mortality based on hypertension status. Ann Transl Med 2020;8(23):1580. doi: 10.21037/atm-20-1155",James,16,5,ADA FPG or ADA HbA1c,1,PreDM(+) & HTN(+),1,1,0,0,0,0,0,0,0,NHANES,USA,2020,1994-2014,8.4,1,1,"age, gender, smoking, education, race, body mass index, cardiovascular disease at baseline, cancer at baseline, total cholesterol, high-density-lipoprotein cholesterol, energy intake, estimated glomerular filtration rate, the use of statin, antiplatelet drugs. CVD, cardiovascular disease; DM, diabetes mellitus; HTN, hypertension; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; CI, confidence interval.",Hypertension,34047,17613,16434,44.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,7.4,NA,NA,NA,NA,NA,29.02458366,28.31431329,29.78580991,NA,NA,NA,41.9,NA,NA,92.1,NA,NA,27.9,NA,NA,122,NA,NA,69.5,NA,NA,0,NA,NA,NA,1.29,1.07,1.56,1.41,1.21,1.63,NA,NA,NA,2.28,1.24,4.2,1.96,1.32,2.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Huang et al., 2020","Huang YQ, Liu L, Huang JY, Chen CL, Yu YL, Lo K, Feng YQ. Prediabetes and risk for all-cause and cardiovascular mortality based on hypertension status. Ann Transl Med 2020;8(23):1580. doi: 10.21037/atm-20-1155",James,16,5,ADA FPG or ADA HbA1c,1,PreDM(+) & HTN(-),1,1,0,0,0,0,0,0,0,NHANES,USA,2020,1994-2015,8.4,1,1,"age, gender, smoking, education, race, body mass index, cardiovascular disease at baseline, cancer at baseline, total cholesterol, high-density-lipoprotein cholesterol, energy intake, estimated glomerular filtration rate, the use of statin, antiplatelet drugs. CVD, cardiovascular disease; DM, diabetes mellitus; HTN, hypertension; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; CI, confidence interval.",Hypertension,34047,17613,16434,44.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,7.4,NA,NA,NA,NA,NA,29.02458366,28.31431329,29.78580991,NA,NA,NA,41.9,NA,NA,92.1,NA,NA,27.9,NA,NA,122,NA,NA,69.5,NA,NA,0,NA,NA,NA,1.1,0.87,1.38,1.02,0.87,1.21,NA,NA,NA,1.66,0.8,3.46,1.08,0.67,1.73,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Schottker et al., 2013",DOI 10.1007/s00125-012-2707-x,James,17,0,NA,1,IFG,0,0,1,0,0,0,0,0,0,ESTHER,Germany,2013,2000-2002,7.9,1,1,"age, sex, systolic blood pressure, current smoking and total cholesterol/HDL-cholesterol ratio",NA,7932,4498,3434,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,48.8,NA,NA,NA,NA,NA,16.2,NA,NA,NA,NA,NA,27,NA,NA,140,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"We defined a composite endpoint of CVE of myocardial infarction, stroke or cardiovascular death.",104,39,65,0.99,0.7,1.41,1.18,0.88,1.58,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Schottker et al., 2013",DOI 10.1007/s00125-012-2707-x,James,17,3,NA,1,5.7%-6.4%,0,0,1,0,0,0,0,0,0,ESTHER,Germany,2013,2000-2003,7.9,1,1,"age, sex, systolic blood pressure, current smoking and total cholesterol/HDL-cholesterol ratio",NA,7932,4498,3434,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,48.8,NA,NA,NA,NA,NA,16.2,NA,NA,NA,NA,NA,27,NA,NA,140,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"We defined a composite endpoint of CVE of myocardial infarction, stroke or cardiovascular death.",207,97,110,0.96,0.73,1.25,1.09,0.86,1.39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Schottker et al., 2013",DOI 10.1007/s00125-012-2707-x,James,17,5,ADA FPG and ADA HbA1c,1,5.6-6.9 mmol/L AND 5.7%-6.4%,0,0,1,0,0,0,0,0,0,ESTHER,Germany,2013,2000-2004,7.9,1,1,"age, sex, systolic blood pressure, current smoking and total cholesterol/HDL-cholesterol ratio",NA,7932,4498,3434,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,48.8,NA,NA,NA,NA,NA,16.2,NA,NA,NA,NA,NA,27,NA,NA,140,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"We defined a composite endpoint of CVE of myocardial infarction, stroke or cardiovascular death.",57,25,32,1.01,0.65,1.57,1.19,0.8,1.77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Sinha et al., 2023",https://doi.org/10.1016/j.cardfail.2022.10.426,James,18,0,NA,0,White,0,0,1,0,0,0,0,1,0,"Lifetime Risk Pooling Project (Atherosclerosis Risk in Communities Study, Cardiovascular Health Study, Coronary Artery Risk Development in Young Adults Study, Framingham Heart Study, Framingham Offspring Cohort Study, Multi-Ethnic Study of Atherosclerosis)",USA,2023,NA,NA,NA,1,"age, education, body mass index, hypertension, hyperlipidemia, and smoking.",NA,17844,9925,7919,49.42765075,47.05904282,49.46028539,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.39284914,26.29571788,26.51458517,NA,NA,NA,24.37850258,23.37793451,25.63252936,NA,NA,NA,27.51642009,27.5856927,27.4295997,118.1486214,116.4949118,120.2212401,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"fatal and nonfatal MI was adjudicated using standardized clinical criteria that consisted of at least 2 of the following: electrocardiographic changes consistent with MI, biomarker elevations consistent with myocardial damage, and/or typical chest pain or International Classification of Diseases (ICD) codes (ICD-9 codes 410414 or equivalent).2",NA,NA,NA,1.33,1.08,1.63,1.21,1.05,1.41,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.2,0.93,1.54,1.38,1.09,1.75
"Sinha et al., 2023",https://doi.org/10.1016/j.cardfail.2022.10.426,James,18,0,NA,0,Black,0,0,1,0,0,0,0,1,0,"Lifetime Risk Pooling Project (Atherosclerosis Risk in Communities Study, Cardiovascular Health Study, Coronary Artery Risk Development in Young Adults Study, Framingham Heart Study, Framingham Offspring Cohort Study, Multi-Ethnic Study of Atherosclerosis)",USA,2023,NA,NA,NA,1,"age, education, body mass index, hypertension, hyperlipidemia, and smoking.",NA,17844,9925,7919,49.42765075,47.05904282,49.46028539,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.39284914,26.29571788,26.51458517,NA,NA,NA,24.37850258,23.37793451,25.63252936,NA,NA,NA,27.51642009,27.5856927,27.4295997,118.1486214,116.4949118,120.2212401,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"fatal and nonfatal MI was adjudicated using standardized clinical criteria that consisted of at least 2 of the following: electrocardiographic changes consistent with MI, biomarker elevations consistent with myocardial damage, and/or typical chest pain or International Classification of Diseases (ICD) codes (ICD-9 codes 410414 or equivalent).3",NA,NA,NA,1.29,0.96,1.73,1.17,0.88,1.56,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.6,1.13,2.27,1.23,0.85,1.78
"Liu et al., 2019",https://onlinelibrary.wiley.com/doi/10.1002/dmrr.3129,James,19,0,NA,0,IFG,1,1,0,0,0,0,0,0,0,NA,China,2019,2007-2014,6,NA,1,"age, mean individual income (monthly), marital status, education level, smoking, drinking, physical activity, body mass index, and levels of total cholesterol, triglycerides, high‐density lipoprotein cholesterol, and low‐density lipoprotein cholesterol",NA,15150,9139,6011,51.33828383,49.86650618,53.5759441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,27.23480528,0.2622168727,68.24337049,NA,NA,NA,23.97481188,24.43551811,23.27436367,NA,NA,NA,NA,NA,NA,0,292,134,158,1,0.8,1.24,1.14,0.94,1.39,135,58,77,0.88,0.64,1.23,1.34,1,1.79,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Tran et al., 2022",J Diabetes Investig 2022; 13: 1897– 1904 doi: 10.1111/jdi.13871,James,20,5,ADA FPG and/or ADA HbA1c,1,Prediabetes,1,0,0,0,0,0,0,0,0,NIPPON DATA90,Japan,2022,1990-2012,22,NA,1,"age, sex, smoking status and drinking status. Model 2: adjustments in model 1 plus cardiovascular risk factors (hypertension, hypertriglyceridemia and low high-density lipoprotein, hypercholesterolemia). Model 3: adjustments in model 1 plus body mass index. Model 4 was adjusted for all variables.",NA,1573,916,657,57.36694215,57.22969432,57.46073059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25.04767959,NA,NA,NA,NA,NA,23.30775588,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,1.61,1.05,2.49,1.49,0.99,2.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Hyvarinen et al., 2009","Diabetes Care 32:348–354, 2009",James,21,1,NA,1,6.1-6.9 mmol/L,0,0,0,0,1,0,0,0,0,"Finland, East-West, FINRISK-1987, FINRISK-1992, FINRISK-2002, Helsinki Policemen Study, Vantaa, [Italy, Cremona], [The Netherlands, Hoorn Study], Zuthpen Study, [Sweden, MONICA], Uppsala, [U.K., Goodinge], Newcastle",Europe (various),2009,NA,10.5,1,1,"age, study, and sex (when men and women combined).",NA,19721,9138,10583,56.24436895,55.33476691,56.95791364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25.52619543,20.65597505,29.74748181,NA,NA,NA,26.62909589,26.72268549,26.51235,139.763653,137.4241628,140.9652273,82.15273059,80.10604071,83.3860909,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,55,10,45,2.04,0.99,4.21,1.05,0.74,1.49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Hyvarinen et al., 2009","Diabetes Care 32:348–354, 2009",James,21,2,NA,1,7.8-11.0 mmol/L,0,0,0,0,1,0,0,0,0,"Finland, East-West, FINRISK-1987, FINRISK-1992, FINRISK-2002, Helsinki Policemen Study, Vantaa, [Italy, Cremona], [The Netherlands, Hoorn Study], Zuthpen Study, [Sweden, MONICA], Uppsala, [U.K., Goodinge], Newcastle",Europe (various),2009,NA,10.5,1,1,"age, study, and sex (when men and women combined).",NA,19670,9047,10623,56.17747579,55.04080762,57.28644997,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25.80870138,21.19409061,29.71702731,NA,NA,NA,26.65964201,26.63328956,26.57026363,139.0691141,137.742285,141.3513182,82.45819178,80.31812213,83.57913635,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,44,9,35,0.9,0.43,1.9,1.43,0.97,2.11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Asgari et al., 2024",Diabetology & Metabolic Syndrome (2024) 16:27 https://doi.org/10.1186/s13098-023-01253-0,James,22,0,NA,0,Non-Obese,1,1,1,0,0,0,0,0,0,"ARIC, Multi-Ethnic Study of Atherosclerosis, Tehran Lipid and Glucose Study",Various,2024,1987-2005,16.6,0,1,"sex (total population), age, non-HDL-C, education levels, hypertension, FH-CVD, and prevalent CVD (except for CVD)",NA,16550,9011,7539,49.6881994,49.42560204,50.00206924,1,94.69745015,94.0013761,95.52943361,NA,NA,NA,3.567667674,2.003473532,5.437272848,NA,NA,NA,26.81370997,27.31120852,26.21907415,NA,NA,NA,23.59239275,19.2606481,28.70412522,NA,NA,NA,27.63318429,27.7832649,27.45380024,117.1998127,116.1902009,118.4065526,73.70143807,73.13509045,74.37836583,0,NA,NA,NA,1.17,1.03,1.34,0.96,0.86,1.08,NA,NA,NA,1.22,0.93,1.59,0.91,0.73,1.13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Cardiovascular disease (CVD) was defined as a combination of CHD events, stroke, or death due to cerebrovascular causes",NA,NA,NA,1.07,0.9,1.27,1.13,1,1.28,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Asgari et al., 2024",Diabetology & Metabolic Syndrome (2024) 16:27 https://doi.org/10.1186/s13098-023-01253-0,James,22,0,NA,0,Obese,1,1,1,0,0,0,0,0,0,"ARIC, Multi-Ethnic Study of Atherosclerosis, Tehran Lipid and Glucose Study",Various,2024,1987-2006,16.6,0,1,"sex (total population), age, non-HDL-C, education levels, hypertension, FH-CVD, and prevalent CVD (except for CVD)",NA,16550,9011,7539,49.6881994,49.42560204,50.00206924,1,94.69745015,94.0013761,95.52943361,NA,NA,NA,3.567667674,2.003473532,5.437272848,NA,NA,NA,26.81370997,27.31120852,26.21907415,NA,NA,NA,23.59239275,19.2606481,28.70412522,NA,NA,NA,27.63318429,27.7832649,27.45380024,117.1998127,116.1902009,118.4065526,73.70143807,73.13509045,74.37836583,0,NA,NA,NA,1.16,1,1.36,1.2,1.04,1.39,NA,NA,NA,1.3,0.97,1.75,1.37,1.06,1.77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Cardiovascular disease (CVD) was defined as a combination of CHD events, stroke, or death due to cerebrovascular causes",NA,NA,NA,1.07,0.88,1.31,1.15,0.97,1.37,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Lin et al., 2017",doi: 10.1111/1753-0407.12490,James,23,5,WHO FPG and/or OGTT 2hPG,1,Prediabetes,0,0,0,0,0,0,0,0,1,REACTION,China,2017,2011-2012,NA,NA,1,"age, BMI, physical activity, current smoking status, current drinking status, systolic blood pressure, high-density lipoprotein cholesterol, use of antihypertensive drugs, and a history of cardiovascular disease",NA,196710,131772,64938,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CKD was defined as eGFR<60 mL/min per 1.73 m^2 ,1395,828,567,1.09,0.98,1.22,1.15,1.02,1.32,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Rentsch et al., 2023",https://doi.org/10.1016/j.lanepe.2023.100693,James,24,4,NA,0,Prediabetes,0,0,0,1,1,0,0,1,0,UK Biobank,UK,2023,2006-2010,11.8,1,1,"age at study entry, socio-demographics (i.e., ethnicity, deprivation), lifestyle characteristics (i.e., smoking status, alcohol consumption, physical activity, body mass index, waist-hip ratio, processed meat and fruit and vegetable intake), and clinical characteristics (i.e., total cholesterol, estimated glomerular filtration rate, C-reactive protein, diagnosed hypertension, use of antihypertensive medication or statins, and family history of cardiovascular disease).",NA,203740,113047,90693,59.69608815,60.13293586,59.15156627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,29.45654118,27.15684008,32.32307234,NA,NA,NA,12.51122116,10.25922492,15.31828917,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,476,213,263,1.14,0.99,1.32,1.04,0.92,1.19,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ICD-10 I21.*, I46.*",625,199,426,1.12,0.97,1.3,1.15,1.15,1.27,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,794,325,469,1.25,1.11,1.41,1.08,0.98,1.19
"Mehrabani-Zeinabad et al., 2023",https://doi.org/10.1038/s41598-023-38221-7,James,25,5,ADA FPG and ADA HbA1c,1,Prediabetes & Non-Obese (Obesity defined by WC),1,1,1,0,0,0,0,0,0,Isfahan Cohort Study,Iran,2023,2001-2018,11.25,1,1,"age, SBP, TG, smoking status, history of heart disease, history of high blood pressure and history of diabetes",NA,4879,2469,2410,50.12901824,NA,NA,1,68.6751404,NA,NA,NA,NA,NA,6.516376307,NA,NA,NA,NA,NA,13.23916991,NA,NA,NA,NA,NA,16.74565075,NA,NA,NA,NA,NA,26.74765936,NA,NA,120.5287784,NA,NA,77.89721254,NA,NA,0,253,NA,NA,1.02,0.47,2.22,1.28,0.83,1.98,253,NA,NA,1.37,0.43,4.33,1.22,0.59,2.53,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CVD events were defined as fatal and non-fatal MI, fatal and non-fatal stroke, sudden cardiac death and unstable angina, based on modified criteria of WHO Expert Committee",253,NA,NA,0.91,0.42,1.98,1.05,0.72,1.55,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Mehrabani-Zeinabad et al., 2023",https://doi.org/10.1038/s41598-023-38221-7,James,25,5,ADA FPG and ADA HbA1c,1,Prediabetes & Obese (Obesity defined by WC),1,1,1,0,0,0,0,0,0,Isfahan Cohort Study,Iran,2023,2001-2020,11.25,1,1,"age, SBP, TG, smoking status, history of heart disease, history of high blood pressure and history of diabetes",NA,4879,2469,2410,50.12901824,NA,NA,1,68.6751404,NA,NA,NA,NA,NA,6.516376307,NA,NA,NA,NA,NA,13.23916991,NA,NA,NA,NA,NA,16.74565075,NA,NA,NA,NA,NA,26.74765936,NA,NA,120.5287784,NA,NA,77.89721254,NA,NA,0,375,NA,NA,0.7,0.42,1.18,1.16,0.56,2.38,375,NA,NA,0.62,0.26,1.47,1.12,0.34,3.63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CVD events were defined as fatal and non-fatal MI, fatal and non-fatal stroke, sudden cardiac death and unstable angina, based on modified criteria of WHO Expert Committee",375,NA,NA,0.83,0.54,1.29,1.32,0.8,2.16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Tian et al., 2024",https://doi.org/10.2337/dca24-0012,James,26,5,ADA FPG or OGTT 2hPG or ADA HbA1c,1,Prediabetes,1,1,0,0,0,0,0,0,0,China Chronic Disease and Risk Factors Surveillance,China,2024,2013-2014,6,1,1,"age (5-year group), sex (male or female), residence (urban or rural), education (junior high school and below, high school, college and above), household income (<¥20,000/year,$¥20,000/year, or not answer/did not know), smoking (never smoked, past smoker, or active smoker), alcohol consumption (excessive, rare/occasional, or nondrinker), physical activity (<150 min/week or $150 min/week), red meat intake (<100 g day or $100 g/day), vegetable and fruit intake (<400 g/day or $400 g/day), BMI (<18.5, 18.5–23.9, 24–27.9, $28 kg/m2), hypertension (yes or no), dyslipidemia (yes or no), and self-reported CVD (yes or no)",NA,116623,73120,43503,50.85734118,NA,NA,1,5.365334454,NA,NA,5.282667227,NA,NA,2.356668067,NA,NA,NA,NA,NA,34.01701723,NA,NA,NA,NA,NA,25.41733277,NA,NA,NA,NA,NA,24.05666807,NA,NA,131.1756437,NA,NA,77.49583718,NA,NA,1,2300,971,1329,1.02,0.93,1.12,1.12,1.03,1.21,995,443,552,1.03,0.89,1.19,1.15,1.01,1.31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Hadaegh et al., 2009",https://link.springer.com/article/10.1007/BF03346527,James,27,5,WHO FPG and OGTT 2hPG,1,IFG/IGT,0,0,1,0,0,0,0,0,0,TLGS,Iran,2009,1999-2001,7.6,1,1,"age, systolic blood pressure, diastolic blood pressure, total cholesterol, HDL-cholesterol, smoking and hypertension medication.",NA,3338,1847,1491,53.07010186,52.09485652,54.27820255,0,5.110748951,5.091136979,5.135043595,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,27.66369083,29.02165674,25.98148893,125.4068904,125.9319978,124.7564051,80.12762133,80.71548457,79.39939638,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CVD was defined as any CHD event, stroke (a new neurological deficit that lasted ≥24 h), or cerebrovascular death",61,25,36,1.07,0.64,1.77,0.99,0.66,1.49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Imano et al., 2018",https://doi.org/10.1253/circj.CJ-17-0950,James,28,2,NA,0,Prediabetes,0,0,0,0,1,1,1,0,0,CIRCS,Japan,2018,1995-2013,14.1,1,1,"age, sex (for total subjects), systolic blood pressure, antihypertensive medication use, atrial fibrillation, serum triglycerides, sex-specific quartiles of body mass index, quartiles of serum high-density lipoprotein-cholesterol, time since the last meal and community",NA,"6,839",4450,2389,58.2002632,57.68213483,59.16538301,0,5.848735195,5.700629213,6.124612809,NA,NA,NA,NA,NA,NA,NA,NA,NA,48.74423161,45.42069663,54.93499372,NA,NA,NA,20.87382658,5.506269663,49.49903725,NA,NA,NA,23.45525662,23.45642697,23.4530766,136.309402,135.1880899,138.3980745,80.3509285,79,82.8673085,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,49,17,32,1.66,0.98,2.82,1.9,1.24,2.9,33,11,22,2.17,1.12,4.24,1.82,1.09,3.02,15,6,9,1.24,0.52,2.98,2.03,0.9,4.56,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"De Jong et al., 2020",https://doi.org/10.2337/dc19-2363,James,29,3,NA,0,Prediabetes,0,0,0,1,0,0,0,0,0,UK Biobank,UK,2020,2006-2018,9,0,1,"*The main effects model is adjusted for age, smoking (never, former, current), BMI, systolic blood pressure, lipid-lowering medication, cholesterol, antihypertensive medication, and the Townsend social deprivation score. **The full interaction model is additionally adjusted for interaction terms between each variable and sex",NA,446689,252531,194158,56.08684655,56.11456574,56.05079368,NA,NA,NA,NA,5.373104554,5.361257826,5.372578003,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10.07091959,8.612578258,11.96770671,NA,NA,NA,27.09115783,26.781786,27.49354134,137.589237,135.0350939,140.9112754,82.38986857,80.73277974,84.54515601,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Myocardial Infarcation,1129,390,739,1.25,1.11,1.4,1.17,1.17,1.27,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Ramezankhani et al., 2022",https://doi.org/10.1186/s13293-022-00421-7,James,30,5,ADA FPG or OGTT 2hPG,1,Prediabetes,0,0,0,0,1,1,0,0,0,TLGS,Iran,2022,1999-2018,17.9,1,1,"adjusted for age, BMI, hypertension, T2D, smoking status, TC, educational level, history of CHD, FH-CVD and lipid lowering drugs.",NA,4562,2438,2124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.27,0.82,1.96,1.22,0.83,1.81,NA,NA,NA,1.58,0.98,2.57,1.18,0.76,1.82,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Levitzky et al., 2008",https://doi.org/10.1016/j.jacc.2007.09.038,James,31,0,NA,1,100-125 mg/dL,0,0,1,1,0,0,0,0,0,Framingham Offspring Cohort,USA,2008,1983-2004,6.3,1,1,"age, systolic blood pressure, hypertension treatment, total cholesterol/HDL ratio, current smoking, and BMI.",NA,3634,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Cardiovascular disease was defined as any CHD event, stroke, transient ischemic attack (TIA), intermittent claudication, congestive heart failure, or CVD death.",NA,NA,NA,1.4,0.9,2.1,1.1,0.8,1.4,"Coronary heart disease included cases of myocardial infarction, stable and unstable angina pectoris, and CHD death",NA,NA,NA,1.7,1,3,0.9,0.9,1.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Levitzky et al., 2008",https://doi.org/10.1016/j.jacc.2007.09.038,James,31,1,NA,1,110-125 mg/dL,0,0,1,1,0,0,0,0,0,Framingham Offspring Cohort,USA,2008,1983-2005,6.3,1,1,"age, systolic blood pressure, hypertension treatment, total cholesterol/HDL ratio, current smoking, and BMI.",NA,3634,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Cardiovascular disease was defined as any CHD event, stroke, transient ischemic attack (TIA), intermittent claudication, congestive heart failure, or CVD death.",NA,NA,NA,2.1,1.2,3.6,1,0.7,1.5,"Coronary heart disease included cases of myocardial infarction, stable and unstable angina pectoris, and CHD death",NA,NA,NA,2.2,1.1,4.4,0.9,0.9,1.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Djupsjo et al., 2022",https://doi.org/10.1186/s12933-022-01699-y,James,32,2,NA,0,Dysglycemia,1,1,0,1,1,0,0,1,0,NA,Sweden,2022,2006-2016,3.9,0,1,"age, sex, date, hospital, and all covariates listed in Table 1, and fnally adjusted for WBC",NA,603078,313102,289976,47.47127138,NA,NA,0,6.256822501,NA,NA,NA,NA,NA,NA,NA,NA,3.708187001,NA,NA,7.593420752,NA,NA,1.841252375,NA,NA,NA,NA,NA,96.37736412,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,9858,4387,5471,1.27,1.22,1.31,1.14,1.11,1.18,2335,951,1384,1.39,1.28,1.5,1.17,1.1,1.25,3748,1599,2149,1.29,1.22,1.37,1.17,1.11,1.23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Myocardial Infarcation,3030,910,2120,1.46,1.35,1.58,1.35,1.35,1.42,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1907,754,1153,1.19,1.1,1.3,1.05,0.99,1.13
"Ramezankhani et al., 2023",https://doi.org/10.1038/s41598-023-50028-0,James,33,5,ADA FPG or OGTT 2hPG,1,Prediabetes,0,0,0,1,0,0,0,0,0,TLGS,Iran,2023,1999-2018,17.9,1,1,"age, smoking status, BMI, SBP, education, TC, antihypertensive and lipid-lowering drugs, and FH-CVD",NA,6519,3549,2970,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"cases of defnite myocardial infarction (MI) diagnosed through electrocardiogram (ECG) and biomarkers, probable MI diagnosed by positive ECG fndings along with cardiac symptoms or signs but with biomarkers showing negative or inconclusive results, unstable angina pectoris, angiographic-proven CHD, and CHD-related death. Nonfatal MI and CHD-related death (including fatal MI) were categorized as hard CHD",NA,NA,NA,1.34,1.05,1.71,1.13,1.13,1.37,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Smith et al., 2002",https://doi.org/10.1001/archinte.162.2.209,James,34,2,NA,1,"OGTT 2hPG (+), FPG (-)",0,0,1,0,0,0,0,0,0,The Cardiovascular Health Study,USA,2002,1989-1999,8.5,NA,1,"Age-, race-, and sex- (where appropriate) adjusted",NA,3729,2258.7,1470.3,73.13649772,NA,NA,1,99.85760257,NA,NA,NA,NA,NA,14.4762671,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11.8412443,NA,NA,NA,NA,NA,26.09688925,NA,NA,135.3175114,NA,NA,70.3175114,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,193,96,97,1.13,0.87,1.45,1.34,1.04,1.72,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Smith et al., 2002",https://doi.org/10.1001/archinte.162.2.209,James,34,5,WHO FPG and OGTT 2hPG ,1,"OGTT 2hPG (+), FPG (+)",0,0,1,0,0,0,0,0,0,The Cardiovascular Health Study,USA,2002,1989-2000,8.5,NA,1,"Age-, race-, and sex- (where appropriate) adjusted",NA,3729,2258.7,1470.3,73.13649772,NA,NA,1,99.85760257,NA,NA,NA,NA,NA,14.4762671,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11.8412443,NA,NA,NA,NA,NA,26.09688925,NA,NA,135.3175114,NA,NA,70.3175114,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,60,26,34,1.1,0.52,2.37,1.54,0.92,2.58,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Song et al., 2023",https://doi.org/10.1186/s12933-023-01750-6,James,35,5,ADA FPG or WHO FPG or ADA HbA1c or IEC HbA1c,1,Prediabetes,0,0,1,0,0,0,0,0,0,"Fuwai Hospital, China",China,2023,2013,6.1,1,1,"age, sex, medical history of hypertension, hyperlipidemia, smoking status, alcoholic consumption, body mass index, heart rate, total cholesterol, LDL, HDL, hsCRP, D-Dimer and triple vessel disease",NA,946,279,667,58.42952431,NA,NA,0,5.131871036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,60.89229387,NA,NA,NA,NA,NA,42.59778013,NA,NA,NA,NA,NA,25.42360465,NA,NA,126.8065328,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MACE, which was a composite endpoint of all-cause death, non-fatal myocardial infarction and repeated ischemia-driven revascularization",58,11,47,2.213,0.731,6.696,1.597,0.959,2.658,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Golabi et al., 2023",https://doi.org/10.1016/j.metabol.2023.155642,James,36,5,ADA FPG or ADA HbA1c,1,Prediabetes,1,1,0,0,0,0,0,0,0,NHANES 1988-1994,USA,2023,1988-2019,26.7,1,1,"age, sex, race, income, education, smoking, physical activity, and healthy eating.",NA,10357,5801.8423,4555.1577,42.41401757,NA,NA,1,92.59731679,NA,NA,5.180401661,NA,NA,3.50879888,NA,NA,NA,NA,NA,36.3668012,NA,NA,NA,NA,NA,27.53093367,NA,NA,NA,NA,NA,26.26577194,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,4.59,1.39,15.19,1.12,0.35,3.56,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Liu et al., 2017",doi: 10.1111/1753-0407.12380,James,37,0,NA,0,IFG,0,0,1,0,0,0,0,0,0,"ChinaMUCA, China Cardiovascular Health Study",China,2017,1998-2008,7.8,NA,1,"age (every 10 years), gender, body mass index, smoking status (never smoker, former smoker, current smoker), drinking status (never drinker, drinker), work-related physical activity, education, hypertension status (yes vs. no), high triglyceride (yes vs. no), region (south, north), area (urban, rural), and family history of atherosclerotic cardiovascular disease (ASCVD); gender, region and area were not adjusted for in corresponding subgroup analyses.",NA,16827,8818,8009,48.5902597,NA,NA,1,92.42918524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.27333452,NA,NA,NA,NA,NA,23.63139003,NA,NA,124.2337969,NA,NA,79.14290129,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ASCVD is defined as the first occurrence of non-fatal myocardial infarction (MI), CHD death, or fatal or non-fatal stroke.",NA,NA,NA,1.22,0.86,1.73,0.88,0.65,1.18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Yuan et al., 2021",doi: 10.1111/jdi.13361,James,38,5,ADA FPG or ADA HbA1c,1,Prediabetes,1,0,1,0,0,0,0,0,0,"Fuwai Hospital, China",China,2021,2004-2011,7.5,1,1,"sex, history of smoking, previous stroke, hypertension, age, peripheral artery disease, hyperlipidemia, left main disease, chronic kidney disease, body mass index, treatment strategy, left ventricular ejection fraction (LVEF), clinical presentation and SYNTAX score (≤22, 23–32 or ≥33).",Three-vessel CAD,5173,877,4296,60.78237,NA,NA,0,5.229421999,NA,NA,5.467658999,NA,NA,NA,NA,NA,NA,NA,NA,65.841214,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25.752948,NA,NA,NA,NA,NA,NA,NA,NA,0,240,42,198,0.83,0.57,1.23,1,0.84,1.19,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"all-cause death, myocardial infarction (MI) and stroke",437,78,359,0.91,0.68,1.21,1.01,0.89,1.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Lee et al., 2018",https://doi.org/10.1186/s12933-018-0694-z,James,39,5,ADA FPG and/or OGTT 2hPG,1,Prediabetes,1,0,0,1,1,0,0,0,0,NHIS-HEALS,South Korea,2018,2002-2013,8,1,1,"adjusted for age, sex, socioeconomic status, physical activity, smoking status, alcohol consumption, body mass index, blood pressure, total cholesterol, Charlson comorbidity index, and baseline fasting glucose leve",NA,260487,110678.478,149808.522,53.78528257,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23.81886774,NA,NA,125.4320742,NA,NA,78.77547094,NA,NA,0,1601,388,1213,1.09,0.97,1.22,1.07,1.01,1.14,NA,NA,NA,NA,NA,NA,NA,NA,NA,1274,484,790,1.03,0.94,1.14,1.05,0.97,1.14,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Myocardial Infarcation,225,42,183,1.11,0.78,1.57,1.1,1.1,1.31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Succurro et al., 2020",https://doi.org/10.2337/dc20-1401,James,40,5,ADA FPG or OGTT 2hPG or ADA HbA1c,1,Prediabetes,0,0,1,0,0,0,0,0,0,CATAMERI,Italy,2020,2006-2019,5.6,NA,1," age; BMI; smoking status; SBP and DBP; total, LDL, and HDL cholesterol; triglycerides; HOMA-IR index; hs-CRP; fibrinogen; and WBC count",NA,2118,1082,1054,54.80453258,53.63031423,55.0740038,1,94.47119924,91.04251386,96.37760911,5.524362606,5.411460259,5.545920304,6.132011331,2.66987061,9.581404175,NA,NA,NA,NA,NA,NA,NA,NA,NA,18.89848914,13.49833641,24.11935484,NA,NA,NA,30.10083097,29.90462107,29.74516129,132.5590179,128.3512015,134.6148008,81.1822474,77.6857671,83.38519924,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Composite CVD was defined by the presence of CHD and/or cerebrovascular disease.,NA,NA,NA,1.16,0.42,3.14,1.21,0.63,2.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Balkau 2004,DOI 10.1007/s00125-004-1574-5,James,41,5,WHO FPG and/or OGTT 2hPG,1,IGT and/or IFG,0,1,0,0,0,0,0,0,0,DECODE,Europe (various),2004,NA,5.2,0,1,"adjusted for age and centre, and then adjusted for all factors",NA,24479.01,8550.72,15928.29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.73,1.11,2.68,1.22,1,1.49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Thrainsdottir et al., 2005",https://doi.org/10.1097/01.hjr.0000173105.91356.4d,James,42,5,ADA FPG or OGTT 2hPG,1,Abnormal Glucose Regulation,0,0,0,1,0,0,0,0,0,Reykjavik Study,Iceland,2005,1996-2001,21.5,0,1,"adjusted for dissimilarities in age, body mass index, previous ischaemic heart disease, systolic blood pressure, blood cholesterol and smoking habits",NA,18098,9467,8631,54.26483037,54.9087673,53.55852161,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13.06249862,12.93584029,13.2014251,31.07640623,27.75473751,34.7198123,NA,NA,NA,47.21045972,39.85416711,34.7198123,NA,NA,NA,25.2958559,24.96718073,25.65636659,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Myocardial Infarcation,216,107,109,1.2,1,1.5,1.1,1.1,1.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"Thrainsdottir et al., 2005",https://doi.org/10.1097/01.hjr.0000173105.91356.4d,James,42,5,ADA FPG or OGTT 2hPG,1,Abnormal Glucose Regulation + Heart Failure,0,0,0,1,0,0,0,0,0,Reykjavik Study,Iceland,2005,1996-2002,21.5,0,1,"adjusted for dissimilarities in age, body mass index, previous ischaemic heart disease, systolic blood pressure, blood cholesterol and smoking habits",NA,18098,9467,8631,54.26483037,54.9087673,53.55852161,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13.06249862,12.93584029,13.2014251,31.07640623,27.75473751,34.7198123,NA,NA,NA,47.21045972,39.85416711,34.7198123,NA,NA,NA,25.2958559,24.96718073,25.65636659,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Myocardial Infarcation,30,10,20,1.6,0.9,2.9,1.5,1.5,2.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA